Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001545:Benserazide / Q000494:pharmacology; D001921:Brain / Q000502:physiology; D001923:Brain Chemistry / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000032:analysis; D004149:Dioxoles / Q000494:pharmacology; D004298:Dopamine / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology*; D005470:Fluorometry; D006885:Hydroxybutyrates / Q000494:pharmacology; D007783:Lactones / Q000494:pharmacology; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000201:enzymology* / Q000502:physiology; D010648:Phenylacetates / Q000032:analysis; D010879:Piperazines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D009435:Synaptic Transmission; D013997:Time Factors; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*
D004149:Dioxoles; D006885:Hydroxybutyrates; D007783:Lactones; D010648:Phenylacetates; D010879:Piperazines; D011743:Pyrimidines; D014316:Tritium; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D014446:Tyrosine 3-Monooxygenase; D001058:Apomorphine; D004298:Dopamine